Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis.

Literature DB >> 17163263

Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis.

Hakan Alagozlu¹, Mehmet Cindoruk, Selahattin Unal.

Abstract

Hypertriglyceridaemia is a well known risk factor for acute pancreatitis. Hypertriglyceridaemia may be primary in origin or secondary to alcohol abuse, diabetes mellitus, pregnancy or use of drugs. In this case report, the cause of acute pancreatitis was tamoxifen. We report on a patient with tamoxifen-induced acute pancreatitis and hypertriglyceridaemia who was successfully treated with insulin infusion and long-term gemfibrozil.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2006 PMID： 17163263 DOI： 10.2165/00044011-200626050-00007

Source DB: PubMed Journal: Clin Drug Investig ISSN： 1173-2563 Impact factor: 2.859

30 in total

Review 1. Side effects of adjuvant treatment of breast cancer.

Authors: C L Shapiro; A Recht
Journal: N Engl J Med Date: 2001-06-28 Impact factor: 91.245

2. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities.

Authors: D Yadav; S Nair; E P Norkus; C S Pitchumoni
Journal: Am J Gastroenterol Date: 2000-11 Impact factor: 10.864

3. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.

Authors: R Malmström; C J Packard; M Caslake; D Bedford; P Stewart; H Yki-Järvinen; J Shepherd; M R Taskinen
Journal: Diabetes Date: 1998-05 Impact factor: 9.461

4. Effect of tamoxifen on serum lipid metabolism.

Authors: Y Hozumi; M Kawano; T Saito; M Miyata
Journal: J Clin Endocrinol Metab Date: 1998-05 Impact factor: 5.958

5. Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery.

Authors: Y Hozumi; M Kawano; M Miyata
Journal: Endocr J Date: 1997-10 Impact factor: 2.349

6. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen.

Authors: M Noguchi; T Taniya; K Tajiri; K Miwa; I Miyazaki; H Koshino; H Mabuchi; A Nonomura
Journal: Br J Surg Date: 1987-07 Impact factor: 6.939

7. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.

Authors: A Lennertz; K G Parhofer; W Samtleben; T Bosch
Journal: Ther Apher Date: 1999-08

8. [Severe hypertriglyceridemia induced by tamoxifen].

Authors: M Taira; N Takasu; I Komiya
Journal: Nihon Ronen Igakkai Zasshi Date: 1998-11

9. [Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].

Authors: Kozo Koshizuka; Masaru Serizawa; Norio Hasuda; Kazushige Furuya; Naruaki Mouri; Kunio Takano; Masahiko Matsumoto
Journal: Gan To Kagaku Ryoho Date: 2004-07

10. Severe hypertriglyceridaemia and hypercholesterolaemia associated with tamoxifen use.

Authors: B M Colls; P M George
Journal: Clin Oncol (R Coll Radiol) Date: 1998 Impact factor: 4.126

11 in total

Review 1. A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.

Authors: Nahla E El-Ashmawy; Rania M Khalil
Journal: Tumour Biol Date: 2013-12-12

Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis.

Review 1. Side effects of adjuvant treatment of breast cancer.

2. Nonspecific hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities.

3. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.

4. Effect of tamoxifen on serum lipid metabolism.

5. Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery.

6. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen.

7. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.

8. [Severe hypertriglyceridemia induced by tamoxifen].

9. [Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].

10. Severe hypertriglyceridaemia and hypercholesterolaemia associated with tamoxifen use.

Review 1. A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.

2. Altered phospholipid transfer protein gene expression and serum lipid profile by topotecan.

3. Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus.

Review 4. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management.

Review 5. Drug-induced pancreatitis : incidence, management and prevention.

6. Tamoxifen Induced Pancreatitis: An Unusual Complication of Commonly used Drug.

7. Malignancy-associated dyslipidemia.

8. Acute Pancreatitis Caused by Tamoxifen-Induced Severe Hypertriglyceridemia After 4 Years of Tamoxifen Use.

9. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

10. [Major hypertriglyceridemia on tamoxifen].